{"title":"Correction to “A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases”","authors":"","doi":"10.1155/cdr/9764793","DOIUrl":null,"url":null,"abstract":"<p>W. Li, D. Wang, C. Lin, et al., “A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases,” <i>Cardiovascular Therapeutics</i> 2025, no. 1 (2025): 1–29, https://doi.org/10.1155/cdr/6684099.</p><p>In the article titled “A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases,” incorrect funding details were included.</p><p>The correct funding statement should read:</p><p>This work was funded by the Fifth Batch of National Outstanding Traditional Chinese Medicine Clinical Talent Cultivation Program (National Administration of Traditional Chinese Medicine, Document No. [2022] 239) and the Guangxi First-Class Discipline Construction Project (Gui Jiao Ke Yan [2022] No. 1).</p><p>We apologize for this error.</p>","PeriodicalId":9582,"journal":{"name":"Cardiovascular Therapeutics","volume":"2026 1","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12931147/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/cdr/9764793","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
W. Li, D. Wang, C. Lin, et al., “A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases,” Cardiovascular Therapeutics 2025, no. 1 (2025): 1–29, https://doi.org/10.1155/cdr/6684099.
In the article titled “A Meta-Analysis of the Incidence of Adverse Reactions of Statins in Various Diseases,” incorrect funding details were included.
The correct funding statement should read:
This work was funded by the Fifth Batch of National Outstanding Traditional Chinese Medicine Clinical Talent Cultivation Program (National Administration of Traditional Chinese Medicine, Document No. [2022] 239) and the Guangxi First-Class Discipline Construction Project (Gui Jiao Ke Yan [2022] No. 1).
期刊介绍:
Cardiovascular Therapeutics (formerly Cardiovascular Drug Reviews) is a peer-reviewed, Open Access journal that publishes original research and review articles focusing on cardiovascular and clinical pharmacology, as well as clinical trials of new cardiovascular therapies. Articles on translational research, pharmacogenomics and personalized medicine, device, gene and cell therapies, and pharmacoepidemiology are also encouraged.
Subject areas include (but are by no means limited to):
Acute coronary syndrome
Arrhythmias
Atherosclerosis
Basic cardiac electrophysiology
Cardiac catheterization
Cardiac remodeling
Coagulation and thrombosis
Diabetic cardiovascular disease
Heart failure (systolic HF, HFrEF, diastolic HF, HFpEF)
Hyperlipidemia
Hypertension
Ischemic heart disease
Vascular biology
Ventricular assist devices
Molecular cardio-biology
Myocardial regeneration
Lipoprotein metabolism
Radial artery access
Percutaneous coronary intervention
Transcatheter aortic and mitral valve replacement.